Retinal Disorders: Cellular Mechanisms and Targeted Therapy
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 53
Special Issue Editor
Interests: molecular mechanisms of retinal diseases including inherited retinal diseases; inherited glaucoma; inherited optic neuropathy; age-related macular degeneration
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Over 300 genes have been identified for inherited eye diseases and yet additional novel genes and mutations are identified every year. This is due to the improvement of whole genome sequencing, resulting from short-read to long-read genome sequencing and software analysis. These novel mutations can occasionally explain disease cause and drastically change the priority of therapeutic developments. However, for each novel disease-associated gene, molecular functional studies are required to prove its involvement in disease onset. Fortunately, in recent decades, functional studies have significantly improved through the use of omics technologies, iPS cells, gene editing, single-cell analysis, and AI. Since the approval of the gene therapy LuxturnaThis Special Issue focuses on the molecular mechanisms of disease onset for inherited ocular diseases and the development of novel therapeutics. Diseases of interest include inherited eye diseases in the cornea, lens, retina, optic nerve, and sclera.
Dr. Takeshi Iwata
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inherited eye diseases
- genome
- omics
- gene editing
- iPS cells
- animal models
- single cell analysis
- AI
- epigenetics
